MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CERS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cerus (CERS) Ownership - Who owns Cerus?

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Medical Specialties
Address
1220 Concord Avenue
Phone
+1 925 288-6000
Employees
288
Web
https://www.cerus.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
243.46M
P/E Ratio
N/A
Total Cash
80.92M
Projected Growth
N/A
Total Debt
99.45M
Revenue
185.14M
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash/Share
0.42
Total Debt/Equity
7.28
Revenue/Share
1.03 USD as % of share price

Fundamentals

CERS
Capitalization
243M
P/E Ratio
N/A
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash
80.9M
Total Cash/Share
0.42
Total Debt
99.4M
Total Debt/Equity
7.28
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.03%
Revenue
185M
ROE
N/A
Book Value
55.5M
P/B Ratio
4.39
Cash Flow
N/A
Earnings
-0.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
191K
Current Ratio
2.32
Current Revenue Per Employee
153875.44
Dividends Per Share - Security
N/A
EBITDA
-8.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
58.80
Revenue To Assets
-9.57
Shares Held By Institutions
609M
Shares Outstanding - Current
192M
Total Liabilities
151M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-17.532
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CERS
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For CERS
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CERS showed earnings on August 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a developer of the INTERCEPT Blood System for platelets and plasma

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1220 Concord Avenue
Phone
+1 925 288-6000
Employees
288
Web
https://www.cerus.com